Gudrun Gatz

724 total citations
28 papers, 565 citations indexed

About

Gudrun Gatz is a scholar working on Gastroenterology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gudrun Gatz has authored 28 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Gastroenterology, 24 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gudrun Gatz's work include Gastroesophageal reflux and treatments (26 papers), Eosinophilic Esophagitis (20 papers) and Helicobacter pylori-related gastroenterology studies (20 papers). Gudrun Gatz is often cited by papers focused on Gastroesophageal reflux and treatments (26 papers), Eosinophilic Esophagitis (20 papers) and Helicobacter pylori-related gastroenterology studies (20 papers). Gudrun Gatz collaborates with scholars based in Germany, United Kingdom and Canada. Gudrun Gatz's co-authors include Karna Dev Bardhan, T Scholten, Hubert Mönnikes, David Armstrong, Bernd Pfaffenberger, P. Berghöfer, Vincenzo Stanghellini, Winfried Beil, Anton Gillessen and Irvin M. Modlin and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Gudrun Gatz

28 papers receiving 537 citations

Peers

Gudrun Gatz
Robert Bulat United States
Jafar Jafari United Kingdom
I Mohammed United Kingdom
N Ahluwalia United Kingdom
Ken Trimble United Kingdom
Cindy Johnson United States
Gudrun Gatz
Citations per year, relative to Gudrun Gatz Gudrun Gatz (= 1×) peers Maria Pía Caldarella

Countries citing papers authored by Gudrun Gatz

Since Specialization
Citations

This map shows the geographic impact of Gudrun Gatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Gatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Gatz more than expected).

Fields of papers citing papers by Gudrun Gatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gudrun Gatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Gatz. The network helps show where Gudrun Gatz may publish in the future.

Co-authorship network of co-authors of Gudrun Gatz

This figure shows the co-authorship network connecting the top 25 collaborators of Gudrun Gatz. A scholar is included among the top collaborators of Gudrun Gatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gudrun Gatz. Gudrun Gatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scholten, T, et al.. (2007). Pantoprazole On-Demand Effectively Treats Symptoms in Patients with Gastro-Oesophageal Reflux Disease. Clinical Drug Investigation. 27(4). 287–296. 5 indexed citations
2.
Mönnikes, Hubert, Bernd Pfaffenberger, Gudrun Gatz, J Hein, & Karna Dev Bardhan. (2007). Novel Measurement of Rapid Treatment Success with ReQuest<sup>TM</sup>: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole. Digestion. 75(Suppl. 1). 62–68. 23 indexed citations
3.
Stanghellini, Vincenzo, David Armstrong, Hubert Mönnikes, et al.. (2007). Determination of ReQuest<sup>TM</sup>-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 75(Suppl. 1). 55–61. 3 indexed citations
4.
Bardhan, Karna Dev, Vincenzo Stanghellini, David Armstrong, et al.. (2007). International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease. Digestion. 75(Suppl. 1). 48–54. 7 indexed citations
8.
Scholten, T, et al.. (2005). Pilot Study of On-Demand Therapy with Pantoprazole 20mg for Long-Term Treatment in Patients with??Mild Gastro-Oesophageal Reflux Disease. Clinical Drug Investigation. 25(10). 633–642. 4 indexed citations
10.
Stanghellini, Vincenzo, David Armstrong, Hubert Mönnikes, et al.. (2005). Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 71(3). 145–151. 24 indexed citations
11.
Mönnikes, Hubert, Bernd Pfaffenberger, Gudrun Gatz, J Hein, & Karna Dev Bardhan. (2005). Novel Measurement of Rapid Treatment Success with ReQuestTM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole. Digestion. 71(3). 152–158. 15 indexed citations
12.
Bardhan, Karna Dev, Vincenzo Stanghellini, David Armstrong, et al.. (2004). Evaluation of GERD Symptoms during Therapy. Part I. Digestion. 69(4). 229–237. 63 indexed citations
13.
Gillessen, Anton, et al.. (2004). 40 mg Pantoprazole and 40 mg Esomeprazole Are Equivalent in the Healing of Esophageal Lesions and Relief from Gastroesophageal Reflux Disease???related Symptoms. Journal of Clinical Gastroenterology. 38(4). 332–340. 56 indexed citations
14.
Bardhan, Karna Dev, et al.. (2004). International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 20(8). 891–898. 39 indexed citations
15.
Gatz, Gudrun, et al.. (2003). Recent Use of Proton Pump Inhibitor‐Based Triple Therapies for the Eradication of H. pylori: A Broad Data Review. Helicobacter. 8(2). 95–104. 38 indexed citations
16.
Simon, Bernd, Peter Müller, Oliviu Pascu, et al.. (2003). Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole. European Journal of Gastroenterology & Hepatology. 15(7). 791–799. 15 indexed citations
17.
Malfertheiner, Peter, T. Kirchner, Manfred Kist, et al.. (2003). Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies. Alimentary Pharmacology & Therapeutics. 17(9). 1125–1135. 28 indexed citations
18.
Körner, T. W., et al.. (2003). Comparable Efficacy of Pantoprazole and Omeprazole in Patients with Moderate to Severe Reflux Esophagitis. Digestion. 67(1-2). 6–13. 20 indexed citations
19.
Scholten, T, et al.. (2003). Once‐daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD‐related symptoms. Alimentary Pharmacology & Therapeutics. 18(6). 587–594. 48 indexed citations
20.
Scholten, T, Gudrun Gatz, & Peter Sander. (2001). On-demand therapy with pantoprazole 20 mg O.D. (PANTO) for the long-term management of GERD patients previously healed from heartburn. Gastroenterology. 120(5). A438–A438. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026